With an untargeted PDT construct using the unfocused laser beam in this proof-of-concept study, there is a greater possibility of 690 nm light penetrating through the tumor into the tongue region, thereby promoting PDP-mediated Cet-IRDye800 delivery into the healthy tongue tissue as well. The gene discussed is PDP1; the disease is neoplasm.